A few further thoughts on industry policy
Peter Rowland contributes to the discussion around “picking winners” in the wake of the federal government’s industry policy release.
DetailsPeter Rowland contributes to the discussion around “picking winners” in the wake of the federal government’s industry policy release.
DetailsThe US subsidiary of defence manufacturer Electro Optic Systems is delivering one of its R400S Mk2D Remote Weapons Stations (pictured) to the US Army which will assess its capabilities. The system, fitted to armoured vehicles in the armies of a number of countries as well as Australia’s Bushmaster, will be delivered to the army Combat…
DetailsThe Northern Territory’s first commerce licence for growing industrial hemp has been awarded.
DetailsAdvanced battery technologies developer 3ME Technology has launched its latest vehicle – the TRITEV underground mining vehicle. The prototype vehicle, a collaborative project between 3ME, Batt Mobile Equipment (BME) and Tritton Underground (Aeris Resources), is a 20 tonne diesel powered vehicle retrofitted to battery electric. The TRITEV is a loader/integrated tool-carrier suitable for deployment into…
DetailsAfter an eight month operation led by the Victorian Environment Protection Authority, the last truckload of contaminated glass waste from Glass Recovery Services (GRS) has been removed from a site in Melbourne for recycling. Here, Aristos Karavias of waste to resources business Repurpose It takes up the story. According to the Environment Protection Authority (EPA)…
DetailsInvestment group Bridgewest Group has bought the Adelaide biologics manufacturing plant operated by pharmaceutical group Pfizer and will develop it into a contract drug and vaccine manufacturer. Pfizer, which operates four Australian factories employing 1,000, sold the Thebarton plant for an undisclosed sum to the tightly-held investment group which founded the BioDuro drug manufacturing operations…
DetailsThe extra A$1 billion funding from January 2021 provides a critical stop-gap. It will help recover some of the lost research momentum. But what will happen after 2021?
DetailsBiotechnology giant CSL has signed a final agreement with the federal government to supply 51 million doses of a University of Queensland-CSL vaccine should the drug be proven effective and safe in clinical trials. CSL’s vaccine subsidiary, Seqirus signed the agreement covering the vaccine candidate V451 and will receive an upfront payment from Canberra. The…
DetailsA new national research centre at Adelaide will be established with $20 million in initial funding, and is geared to helping Australia capture some of the benefits of the current artificial intelligence revolution.
DetailsElectric delivery vehicle developer ACE-EV has been given a $5 million boost in the federal budget and will move to initial production of its three models of small vehicles in Adelaide. The company, which launched its first locally-assembled vehicle with fanfare in August, received the grant from the Future Fuels Fund administered by the Australian…
Details